June 4, 2008
Arno Therapeutics, Inc. Completes $18 Million Financing and Reverse Merger more »

Jan. 18, 2008
Arno Therapeutics Completes License Agreements for the Exclusive Rights to Novel, Targeted Cancer Compounds more »